ArticlePharmacoepidemiology and drug safety2026

Active and Non-Active Comparators Yield Different Estimates of the Association Between Proton Pump Inhibitor Use and Recorded Mortality During Immune Checkpoint Inhibitor Therapy for Advanced Non-Small Cell Lung Cancer.

Yasutaka Ihara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.